83 results
8-K
EQ
Equillium Inc
1 Apr 24
Other Events
8:05am
rates of infection or other adverse clinical signals.
The majority of treatment emergent adverse events (“TEAEs”) were assessed as mild (Grade 1
8-K
EX-99.1
5aqp4js pwquw5
8 Mar 24
Departure of Directors or Certain Officers
4:01pm
424B5
wzbjt
5 Oct 23
Prospectus supplement for primary offering
5:23pm
PRE 14A
zz5lu5zcxvt89pa8
31 Mar 23
Preliminary proxy
4:02pm
425
xlv ujmhh
6 Dec 22
Business combination disclosure
4:53pm
424B3
0g5ykwxqtdslk
10 Nov 22
Prospectus supplement
4:13pm
S-4/A
ad99z
9 Nov 22
Registration of securities issued in business combination transactions (amended)
4:31pm
S-4
yrpr9 xa3fk7ca85ir
26 Oct 22
Registration of securities issued in business combination transactions
9:59pm